(Q30887670)

27 June 2017

Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin (English)

1 reference

27 June 2017

6

Stephen Dewhurst

1 reference

27 June 2017

Julie Richards

1

1 reference

27 June 2017

Michelle Miller

2

1 reference

27 June 2017

Johanna Abend

3

1 reference

27 June 2017

Akiko Koide

4

1 reference

27 June 2017

Shohei Koide

5

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Molecular Biology

27 June 2017

1 reference

27 June 2017

326

1 reference

27 June 2017

5

1 reference

27 June 2017

1475-1488

1 reference

Phage display in pharmaceutical biotechnology

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Bacteriophage display and discovery of peptide leads for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Backbone dynamics of homologous fibronectin type III cell adhesion domains from fibronectin and tenascin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

The fibronectin type III domain as a scaffold for novel binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

The alpha v beta 3 integrin "vitronectin receptor"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Integrin alphavbeta3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of αIIbβ3 and αvβ3 integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Peptide ligands for a sugar-binding protein isolated from a random peptide library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Protein loop grafting to construct a variant of tissue-type plasminogen activator that binds platelet integrin alpha IIb beta 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

In vitro selection of fibronectin gain-of-function mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Crystal structure of the tenth type III cell adhesion module of human fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Crystal structure of the extracellular segment of integrin alpha Vbeta3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Cloning of an integrin beta subunit exhibiting high homology with integrin beta 3 subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Targeting of adenoviral vectors through a bispecific single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Modulation of antibody display on M13 filamentous phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Rapid and efficient site-specific mutagenesis without phenotypic selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Peptides in cell adhesion research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900082-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2836(03)00082-2

1 reference

27 June 2017

1 reference